author-photo

Izumi Mishiro

Takeda Pharmaceutical Company

7

Papers

5

Citations

Citation Trend

Filter By

Papers (5) Sort By

Journal Conference Others

Prediction of residual cognitive disturbances by early response of depressive symptoms to antidepressant treatments in patients with major depressive disorder.

2022 Journal of Affective Disorders
Show All
- Source
- Cite
- Save
Citations (0)
Treatment of Major Depressive Disorder in Japanese Patients with Cancer: A Matched Cohort Study Using Employer-Based Health Insurance Claims Data

2020 Clinical Drug Investigation
Show All
- Source
- Cite
- Save
Citations (1)
Risk of major depressive disorder in spouses of cancer patients in Japan: A cohort study using health insurance-based claims data.

2020 Psycho-oncology
Show All
- Source
- Cite
- Save
Citations (0)
Pre-emptive skin treatments to prevent skin toxicity caused by anti-EGFR antibody: the real-world evidence in Japan

2018 Future Oncology
Show All
- Source
- Cite
- Save
Citations (2)
Post‐marketing surveillance in Japan: Potential best way forward

2017 Pharmacoepidemiology and Drug Safety
Show All
- Source
- Cite
- Save
Citations (0)